Explore more publications!
Yemen Health Report
Got News to Share?

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 15, 2025

Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting
September 15, 2025

Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting

Indeterminate GlobeNewswire
Press Release Biocartis NV: Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test
September 15, 2025

Press Release Biocartis NV: Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test

Indeterminate GlobeNewswire
Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress
September 15, 2025

Entera Bio Reports Positive PK Data for First-in-Class Oral GLP-2 Tablet Treatment for Patients with Short Bowel Syndrome at the 2025 ESPEN Congress

Indeterminate GlobeNewswire
Berry Street Launches GLP-1 Nutrition Pathway Program
September 15, 2025

Berry Street Launches GLP-1 Nutrition Pathway Program

Indeterminate GlobeNewswire
Conceivable Life Sciences asegura $50 millones de dólares en ronda de financiación Serie A
September 15, 2025

Conceivable Life Sciences asegura $50 millones de dólares en ronda de financiación Serie A

Indeterminate GlobeNewswire
Conceivable Life Sciences Secures $50 Million Series A
September 15, 2025

Conceivable Life Sciences Secures $50 Million Series A

Indeterminate GlobeNewswire
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV
September 15, 2025

Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV

Indeterminate GlobeNewswire
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
September 15, 2025

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

Indeterminate GlobeNewswire
Sienna Announces September Dividend
September 15, 2025

Sienna Announces September Dividend

Indeterminate GlobeNewswire
More than 3.7 Million Teens Participate in Planet Fitness' High School Summer Pass™ Program, Building Lifelong Health and Wellness Habits Through Fitness
September 15, 2025

More than 3.7 Million Teens Participate in Planet Fitness' High School Summer Pass™ Program, Building Lifelong Health and Wellness Habits Through Fitness

Indeterminate GlobeNewswire
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
September 15, 2025

Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease

Indeterminate GlobeNewswire
KFSHRC Reduces Emergency Department Inpatient Bed Waiting Time by 75%
September 15, 2025

KFSHRC Reduces Emergency Department Inpatient Bed Waiting Time by 75%

Indeterminate GlobeNewswire
Request for Secretary of State of Texas, Jane Nelson, to Organize a Public Meeting Between Crosetto and CPRIT Scientists Who Have Allocated $3.65 Billion of $6 Billion to Cancer Research
September 15, 2025

Request for Secretary of State of Texas, Jane Nelson, to Organize a Public Meeting Between Crosetto and CPRIT Scientists Who Have Allocated $3.65 Billion of $6 Billion to Cancer Research

Indeterminate GlobeNewswire
Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration
September 15, 2025

Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration

Indeterminate GlobeNewswire
Avalyn to Highlight AURA-IPF Phase 2 Clinical Trial Design for AP02, Inhaled Nintedanib, at the European Respiratory Society International Congress 2025
September 15, 2025

Avalyn to Highlight AURA-IPF Phase 2 Clinical Trial Design for AP02, Inhaled Nintedanib, at the European Respiratory Society International Congress 2025

Indeterminate GlobeNewswire
ABLi Therapeutics to Present “Clinical Breakthrough Lecture” at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
September 15, 2025

ABLi Therapeutics to Present “Clinical Breakthrough Lecture” at the 2025 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult
September 15, 2025

INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult

Indeterminate GlobeNewswire
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
September 15, 2025

Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label

Indeterminate GlobeNewswire
Heroes on the Water Receives $15,000 Sponsorship from Cigna to Support BAMC Therapeutic Program
September 15, 2025

Heroes on the Water Receives $15,000 Sponsorship from Cigna to Support BAMC Therapeutic Program

Indeterminate GlobeNewswire
Picard Medical Reports Second Quarter 2025 Financial Results
September 15, 2025

Picard Medical Reports Second Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions